Table2 Clinical and demographic characteristics of the six audited groups
Characteristics | Baseline group PERIOD 0 | Test Group PERIOD 1 | Post-test group PERIOD 2 | Post-computerized tool group PERIOD 3 | First group of the COVID-19 period PERIOD 4 | Second group of the COVID-19 period PERIOD 5 | P (a) | P (b) | P (c) | P (d) | P (e) | P (f) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | Â | Â | Â | (a) Comparing the baseline group with the test group | (b) Comparing the test group with the post-test group | (c) Comparing the post-test group with the post-computerized tool group | (d) Comparing the post-computerized tool group with the first group of the COVID-19 period | (e) Comparing the first group of the COVID-19 period with the second group of the COVID-19 period | (f) Comparing the second group of the COVID-19 period with the post-computerized tool group |
Number of Interventions, n | 130 | 118 | 124 | 120 | 116 | 152 | Â | Â | Â | Â | Â | Â |
Female, n (%) | 48 (36.9) | 49 (41.5) | 57 (46) | 34 (28.3) | 53 (46) | 57 (37.5) | 0.46 | 0.49 | 0.004* | 0.006* | 0.18 | 0.11 |
Age (yr), mean ± SD | 66.3 ± 11.7 | 68.4 ± 13.8 | 65.8 ± 13.6 | 65 ± 11.1 | 65.7 ± 13.7 | 66.7 ± 14.8 | 0.21 | 0.15 | 0.62 | 0.67 | 0.57 | 0.28 |
Transurethral resection of the prostate, n (%) | 26 (20) | 11 (9.3) | 9 (7.3) | 12 (10) | 4 (3.5) | 11 (7.2) | 0.02* | 0.56 | 0.45 | 0.045* | 0.18 | 0.42 |
Coronary artery bypass grafting, n (%) | 38 (29.2) | 34 (28.8) | 30 (24.2) | 46 (38.3) | 32 (27.6) | 57 (37.5) | 0.94 | 0.42 | 0.02* | 0.08 | 0.09 | 0.89 |
Colorectal surgery, n (%) | 17 (13.1) | 22 (18.6) | 19 (15.3) | 12 (10) | 23 (19.8) | 24 (15.8) | 0.23 | 0.49 | 0.21 | 0.03* | 0.39 | 0.16 |
Hip prosthesis, n (%) | 30 (23.1) | 34 (28.8) | 38 (30.7) | 31 (25.8) | 35 (30.2) | 32 (21.1) | 0.30 | 0.76 | 0.40 | 0.46 | 0.09 | 0.35 |
Endoscopic retrograde cholangiopancreatography, n (%) | 19 (14.6) | 17 (14.4) | 28 (22.6) | 19 (15.8) | 22 (19) | 28 (18.4) | 0.96 | 0.10 | 0.18 | 0.53 | 0.91 | 0.58 |
Antibiotic prophylaxis, n (%) | 113 (86.9) | 109 (92.4) | 104 (83.9) | 107 (89.2) | 98 (84.5) | 124 (81.6) | 0.16 | 0.04* | 0.23 | 0.29 | 0.53 | 0.08 |
Duration of intervention > 3 h, n (%) | 48 (36.9) | 52 (44.1) | 48 (38.7) | 55 (45.8) | 45 (38.8) | 63 (41.5) | 0.25 | 0.40 | 0.26 | 0.27 | 0.66 | 0.47 |
IgE Mediated Penicillin Allergy, n (%) | 6 (4.6) | 6 (5.1) | 11 (8.9) | 6 (5) | 11 (9.5) | 13 (8.6) | 0.86 | 0.25 | 0.24 | 0.18 | 0.79 | 0.25 |